We are always researching better ways to help people living with serious psychiatric and neurological conditions. This ongoing pursuit drives us forward and inspires our innovation to develop new treatments that will improve the lives of millions impacted by brain disorders. At Sunovion, we are dedicated to expanding our portfolio of products that matter most to the people we serve.
We serve the psychiatric community by developing and commercializing products to address mental health conditions such as, bipolar depression and schizophrenia.
Products in Development
From our history of innovation to our future-forward approach to therapeutic advancements, we are committed to uncovering new treatments to transform patients’ lives. Our pipeline highlights a portfolio of investigational products in varied stages of clinical development. Advancing global health care through innovation.